The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial

Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B (2013) Journal of Research in Medical Sciences
Title and abstract of The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial

Key Takeaway

500mg magnesium daily for 8 weeks significantly improved sleep quality, sleep time, melatonin levels, and reduced cortisol in elderly with insomnia.

Summary

This double-blind, placebo-controlled trial examined the effect of magnesium supplementation on sleep quality in 46 elderly adults with primary insomnia.

Key findings:

  • Sleep quality index improved significantly (p < 0.001)
  • Sleep time increased
  • Serum melatonin levels increased
  • Cortisol levels decreased
  • Sleep efficiency improved

Protocol:

  • 500mg magnesium daily for 8 weeks
  • Elderly participants (60-75 years)
  • Measured both subjective and objective markers

Clinical significance:

Provides strong evidence for magnesium's role in sleep regulation, particularly in populations at high risk for deficiency.

Related Interventions

Related Studies